The efficiency of somatic energy metabolism is correlated with cognitive change over the lifespan. This relationship is bidirectional, with improved overall fitness associated with enhanced synaptic function and neuroprotection, and synaptic endangerment occurring in the context of impaired energy metabolism. In this review, we discuss recent advancements in the fields of exercise, dietary energy intake and diabetes, as they relate to neuronal function in the hippocampus. Because hippocampal neurons have energy requirements that are relatively higher than those of other brain regions, they are uniquely poised to benefit from exercise, and to be harmed by diabetes. We view exercise and dietary energy restriction as being associated with enhanced hippocampal plasticity at one end of a continuum, with obesity and diabetes accompanied by cognitive impairment at the other end of the continuum. Understanding the mechanisms for this continuum may yield novel therapeutic targets for the prevention and treatment of cognitive decline following aging, disease, or injury.
Introduction
The global obesity epidemic has been associated with the development of a novel human phenotype. Over the course of human evolution, somatic metabolism developed in relationship to significant energy investments associated with the process of obtaining sustenance. Over the past century, humans have progressed from a state of widespread food insecurity, to the ready availability of inexpensive, calorically dense, highly palatable food products. Concomitantly, humans have reduced energy expenditure during activities of daily life. We have maximized energy influx, while minimizing expenditure, leading to an increase in the proportion of the population that is obese across multiple regions of the world (World Health Organization, 2000) . In this regard, we are a species that evolved a 'thrifty metabolism' that is no longer adaptive under current circumstances.
Insulin resistant diabetes arises from obesity, sedentary lifestyle, and genetic predisposition (Lazar, 2005) . Age is also a risk factor for insulin resistance, with older adults developing type 2 diabetes at a higher rate than middle aged or younger populations (Defronzo, 1981) . Aging is often accompanied by cognitive decline, specifically on tasks that recruit the hippocampus and associated cortical structures (Burke & Barnes, 2010) . Susceptibility to cognitive decline is greater among individuals with type 2 diabetes (Ott et al., 1996; Velayudhan et al., 2010) . Insulin resistance is associated with cognitive impairment among middle aged (Sandeep et al., 2004) and aged individuals without dementia (Bruehl et al., 2009; Convit, Wolf, Tarshish, & de Leon, 2003) . Even in non-diabetic individuals, more efficient glycemic control is correlated with improved cognitive function (Rolandsson, Backeström, Eriksson, Hallmans, & Nilsson, 2008) . Based on these observations, it is likely that neurocognitive function is related to overall somatic metabolism, such that metabolic compromise impairs neuronal plasticity.
Changes in brain structure in insulin resistant diabetes occur within temporal lobe circuits that are also sensitive to aging and Alzheimer's disease (AD). Individuals with insulin resistant diabetes exhibit hippocampal atrophy (Rasgon et al., in press), particularly in the dentate gyrus subfield (Wu et al., 2008) . The entorhinal cortex, which sends the primary afferent input to the hippocampus (van Strien, Cappaert, & Witter, 2009) and exhibits early vulnerability during aging and AD (Mattson & Magnus, 2006) , also displays a reduction in cerebral blood flow in aged individuals with insulin resistant diabetes (Wu et al., 2008) . The extent of hippocampal shrinkage is correlated with body composition, such that type 2 diabetics with greater visceral adiposity have more hippocampal atrophy relative to type 2 diabetics with less abdominal fat (Anan et al., 2010) . Resting-state connectivity among the hippocampus and neocortical regions implicated in cognitive function is also impaired in insulin resistant diabetes (Zhou et al., 2010) . Taken together with the behavioral observations suggesting that cognition is impaired with insulin resistance, the neuroimaging findings provide additional support for a metabolic continuum with consequences for neuronal function.
